Sellas Life Sciences Group logo

Sellas Life Sciences Group Share Price Today

(NASDAQ: SLS)

Sellas Life Sciences Group share price is $1.23 & ₹106.97 as on 6 Mar 2025, 2.30 'hrs' IST

$1.23

0.05

(4.24%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sellas Life Sciences Group share price in Dollar and Rupees. Guide to invest in Sellas Life Sciences Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sellas Life Sciences Group, along with analyst recommendations, forecasts, and comprehensive financials.

Sellas Life Sciences Group share price movements

  • Today's Low: $1.17
    Today's High: $1.23

    Day's Volatility :5.28%

  • 52 Weeks Low: $0.77
    52 Weeks High: $1.84

    52 Weeks Volatility :58.04%

Sellas Life Sciences Group (SLS) Returns

PeriodSellas Life Sciences Group IncIndex (Russel 2000)
3 Months
7.27%
0.0%
6 Months
-4.07%
0.0%
1 Year
-1.67%
0.0%
3 Years
-76.95%
-11.6%

Sellas Life Sciences Group (SLS) Key Statistics

in dollars & INR

Previous Close
$1.18
Open
$1.2
Today's High
$1.23
Today's Low
$1.165
Market Capitalization
$92.7M
Today's Volume
$115.3K
52 Week High
$1.84
52 Week Low
$0.772
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.68
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-535.1%

How to invest in Sellas Life Sciences Group Stock (SLS) from India?

It is very easy for Indian residents to invest directly in Sellas Life Sciences Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sellas Life Sciences Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sellas Life Sciences Group or SLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sellas Life Sciences Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sellas Life Sciences Group shares which would translate to 0.707 fractional shares of Sellas Life Sciences Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sellas Life Sciences Group, in just a few clicks!

Returns in Sellas Life Sciences Group (SLS) for Indian investors in Rupees

The Sellas Life Sciences Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sellas Life Sciences Group investment value today

Current value as on today

₹1,07,463

Returns

₹7,463

(+7.46%)

Returns from Sellas Life Sciences Group Stock

₹2,500 (+2.5%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Sellas Life Sciences Group (SLS)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sellas Life Sciences Group Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Sellas Life Sciences Group

  • Vanguard Group Inc

    2.92%

  • Anson Funds Management LP

    1.52%

  • Geode Capital Management, LLC

    0.93%

  • Citadel Advisors Llc

    0.62%

  • BlackRock Inc

    0.57%

  • Opus Capital Group LLC

    0.30%

Analyst Recommendation on Sellas Life Sciences Group

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Sellas Life Sciences Group(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Sellas Life Sciences Group Stock (SLS)

What analysts predicted

Upside of 374.25%

Target:

$5.83

Current:

$1.23

Insights on Sellas Life Sciences Group Stock (Ticker Symbol: SLS)

  • Price Movement

    In the last 7 days, SLS stock has moved up by 2.6%
  • SLS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 49.9%
  • SLS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 128.3%

Sellas Life Sciences Group Technicals Summary

Sell

Neutral

Buy

Sellas Life Sciences Group is currently in a neutral trading position according to technical analysis indicators.

Sellas Life Sciences Group (SLS) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sellas Life Sciences Group Inc logo
-20.27%
-4.07%
-1.67%
-76.95%
-44.6%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sellas Life Sciences Group Inc logo
NA
NA
NA
-0.54
-5.35
-1.14
NA
0.25
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sellas Life Sciences Group Inc logo
Buy
$92.7M
-44.6%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Sellas Life Sciences Group

SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase 3 clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; and GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009, a highly selective small molecule CDK9 inhibitor, currently under Phase 1 clinical trials. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
Organization
Sellas Life Sciences Group
Employees
16
CEO
Dr. Angelos M. Stergiou M.D., ScD h.c.
Industry
Health Technology

Management People of Sellas Life Sciences Group

NameTitle
Dr. Angelos M. Stergiou M.D., ScD h.c.
Founder, President, CEO & Director
Mr. John Thomas Burns CPA
Senior VP & CFO
Ms. Stacy E. Yeung
VP of Legal Affairs, Head of Compliance & Corporate Secretary
Dr. Dragan Cicic M.D., MBA
Senior Vice President of Clinical Development
Mr. Andrew Elnatan
Senior VP of Regulatory Affairs, CMC & Quality

Important FAQs about investing in SLS Stock from India :

What is Sellas Life Sciences Group share price today?

Sellas Life Sciences Group share price today stands at $1.23, Open: $1.20 ; Previous Close: $1.18 ; High: $1.23 ; Low: $1.17 ; 52 Week High: $1.84 ; 52 Week Low: $0.77.

The stock opens at $1.20, after a previous close of $1.18. The stock reached a daily high of $1.23 and a low of $1.17, with a 52-week high of $1.84 and a 52-week low of $0.77.

Can Indians buy Sellas Life Sciences Group shares?

Yes, Indians can invest in the Sellas Life Sciences Group (SLS) from India.

With INDmoney, you can buy Sellas Life Sciences Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sellas Life Sciences Group at zero transaction cost.

How can I buy Sellas Life Sciences Group shares from India?

It is very easy to buy Sellas Life Sciences Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sellas Life Sciences Group (SLS) be purchased?

Yes, you can buy fractional shares of Sellas Life Sciences Group with INDmoney app.

What are the documents required to start investing in Sellas Life Sciences Group stocks?

To start investing in Sellas Life Sciences Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sellas Life Sciences Group Stock (SLS)?

Today’s highest price of Sellas Life Sciences Group (SLS) is $1.23.

Today’s lowest price of Sellas Life Sciences Group (SLS) is $1.17.

What is today's market capitalisation of Sellas Life Sciences Group?

Today's market capitalisation of Sellas Life Sciences Group SLS is 92.7M

What is the 52 Week High and Low Range of Sellas Life Sciences Group Stock (SLS)?

  • 52 Week High

    $1.84

  • 52 Week Low

    $0.77

What are the historical returns of Sellas Life Sciences Group (SLS)?

  • 1 Month Returns

    -20.27%

  • 3 Months Returns

    -4.07%

  • 1 Year Returns

    -1.67%

  • 5 Years Returns

    -44.6%

Who is the Chief Executive Officer (CEO) of Sellas Life Sciences Group ?

Dr. Angelos M. Stergiou M.D., ScD h.c. is the current Chief Executive Officer (CEO) of Sellas Life Sciences Group.